Details for Patent: RE46365
✉ Email this page to a colleague
Which drugs does patent RE46365 protect, and when does it expire?
Patent RE46365 protects SYMPROIC and is included in one NDA.
This patent has twenty-three patent family members in eighteen countries.
Summary for Patent: RE46365
| Title: | 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| Abstract: | A novel compound which is useful as an agent for treating and/or preventing emesis, vomiting and/or constipation. A compound represented by the formula (I): ##STR00001## wherein R.sup.1 and R.sup.2 are each independently hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted cycloalkyl, optionally substituted aryl etc., R.sup.3 is hydrogen, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkynyl, optionally substituted lower alkoxy etc., R.sup.4 is hydrogen or lower alkyl, R.sup.5 is hydrogen, lower alkyl, cycloalkyl lower alkyl or lower alkenyl, or a pharmaceutically acceptably salt, or a solvate thereof is provided. |
| Inventor(s): | Inagaki; Masanao (Toyonaka, JP), Hara; Shin-ichiro (Toyonaka, JP), Haga; Nobuhiro (Osaka, JP), Tamura; Yoshinori (Toyonaka, JP), Goto; Yoshihisa (Amagasaki, JP), Hasegawa; Tsuyoshi (Toyonaka, JP) |
| Assignee: | Shionogi & Co., Ltd. (Osaka, JP) |
| Application Number: | 15/064,511 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Dosage form; |
Drugs Protected by US Patent RE46365
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bdsi | SYMPROIC | naldemedine tosylate | TABLET;ORAL | 208854-001 | Mar 23, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE46365
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2005-151864 | May 25, 2005 |
| Japan | 2006-065762 | Mar 10, 2006 |
| Japan | PCT/JP2006/310231 | May 23, 2006 |
| PCT Information | |||
| PCT Filed | May 25, 2006 | PCT Application Number: | PCT/JP2006/310454 |
| PCT Publication Date: | November 30, 2006 | PCT Publication Number: | WO2006/126637 |
International Family Members for US Patent RE46365
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006250390 | ⤷ Try a Trial | |||
| Brazil | PI0610343 | ⤷ Try a Trial | |||
| Canada | 2609733 | ⤷ Try a Trial | |||
| China | 101228172 | ⤷ Try a Trial | |||
| Denmark | 1889848 | ⤷ Try a Trial | |||
| European Patent Office | 1889848 | ⤷ Try a Trial | 300996 | Netherlands | ⤷ Try a Trial |
| European Patent Office | 1889848 | ⤷ Try a Trial | 2019C/533 | Belgium | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
